Mirabella Financial Services LLP Trims Stake in Liquidia Corporation $LQDA

Mirabella Financial Services LLP reduced its stake in Liquidia Corporation (NASDAQ:LQDA) by 45.2% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 247,405 shares of the company’s stock after selling 203,827 shares during the quarter. Mirabella Financial Services LLP owned approximately 0.28% of Liquidia worth $5,626,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. NewEdge Advisors LLC purchased a new position in shares of Liquidia during the 2nd quarter valued at about $25,000. Skandinaviska Enskilda Banken AB publ bought a new stake in Liquidia during the 3rd quarter worth approximately $30,000. Steward Partners Investment Advisory LLC lifted its holdings in Liquidia by 24.0% during the second quarter. Steward Partners Investment Advisory LLC now owns 6,200 shares of the company’s stock valued at $77,000 after purchasing an additional 1,200 shares in the last quarter. Tower Research Capital LLC TRC boosted its position in shares of Liquidia by 281.2% in the second quarter. Tower Research Capital LLC TRC now owns 6,679 shares of the company’s stock worth $83,000 after purchasing an additional 4,927 shares during the period. Finally, Blueshift Asset Management LLC purchased a new stake in shares of Liquidia in the second quarter worth $127,000. Institutional investors own 64.54% of the company’s stock.

Liquidia Trading Down 2.6%

Shares of LQDA opened at $35.70 on Tuesday. The stock has a market capitalization of $3.15 billion, a PE ratio of -43.01 and a beta of 0.53. The company’s fifty day moving average is $37.53 and its 200 day moving average is $31.36. The company has a debt-to-equity ratio of 2.97, a quick ratio of 1.84 and a current ratio of 2.01. Liquidia Corporation has a fifty-two week low of $11.26 and a fifty-two week high of $46.67.

Liquidia (NASDAQ:LQDA) last issued its quarterly earnings data on Thursday, March 5th. The company reported $0.15 earnings per share for the quarter, topping the consensus estimate of $0.08 by $0.07. The company had revenue of $92.02 million for the quarter, compared to analysts’ expectations of $87.49 million. Liquidia had a negative return on equity of 209.33% and a negative net margin of 43.53%.The firm’s revenue was up 3072.4% compared to the same quarter last year. Sell-side analysts expect that Liquidia Corporation will post -1.51 earnings per share for the current fiscal year.

Insider Buying and Selling at Liquidia

In other news, CEO Roger Jeffs sold 66,610 shares of the company’s stock in a transaction that occurred on Monday, January 12th. The stock was sold at an average price of $37.43, for a total transaction of $2,493,212.30. Following the transaction, the chief executive officer owned 1,037,528 shares of the company’s stock, valued at approximately $38,834,673.04. This represents a 6.03% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, General Counsel Russell Schundler sold 27,289 shares of the business’s stock in a transaction on Monday, January 12th. The shares were sold at an average price of $37.43, for a total value of $1,021,427.27. Following the transaction, the general counsel owned 579,394 shares of the company’s stock, valued at approximately $21,686,717.42. The trade was a 4.50% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 212,534 shares of company stock valued at $7,964,719. 30.10% of the stock is owned by company insiders.

Analyst Ratings Changes

LQDA has been the topic of a number of recent analyst reports. Oppenheimer raised their price target on Liquidia from $16.00 to $19.00 and gave the company an “underperform” rating in a report on Thursday, March 12th. HC Wainwright lifted their target price on Liquidia from $50.00 to $55.00 and gave the company a “buy” rating in a research note on Friday, March 6th. Needham & Company LLC upped their price target on Liquidia from $52.00 to $54.00 and gave the stock a “buy” rating in a research note on Thursday, March 5th. Raymond James Financial reiterated a “strong-buy” rating on shares of Liquidia in a research report on Thursday, March 5th. Finally, BTIG Research raised their target price on shares of Liquidia from $49.00 to $50.00 and gave the company a “buy” rating in a research note on Thursday, March 5th. Two analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating, one has given a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $42.67.

About Liquidia

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).